Sean O'Leary
Concepts (456)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaccination | 119 | 2025 | 1346 | 19.440 |
Why?
| Vaccines | 38 | 2024 | 396 | 10.920 |
Why?
| Papillomavirus Vaccines | 33 | 2024 | 232 | 8.140 |
Why?
| Influenza Vaccines | 42 | 2025 | 532 | 7.930 |
Why?
| Health Knowledge, Attitudes, Practice | 41 | 2025 | 1276 | 5.950 |
Why?
| Immunization | 27 | 2024 | 411 | 5.800 |
Why?
| Parents | 37 | 2025 | 1307 | 5.340 |
Why?
| Influenza, Human | 25 | 2025 | 600 | 4.980 |
Why?
| Motivational Interviewing | 12 | 2025 | 100 | 4.930 |
Why?
| Immunization Programs | 14 | 2024 | 213 | 4.720 |
Why?
| Vaccination Refusal | 14 | 2022 | 70 | 4.630 |
Why?
| Obstetrics | 14 | 2022 | 161 | 4.530 |
Why?
| Papillomavirus Infections | 20 | 2024 | 293 | 4.520 |
Why?
| Gynecology | 13 | 2022 | 175 | 4.160 |
Why?
| Attitude of Health Personnel | 29 | 2024 | 1090 | 3.650 |
Why?
| Practice Patterns, Physicians' | 25 | 2024 | 1262 | 3.610 |
Why?
| Patient Acceptance of Health Care | 24 | 2022 | 757 | 3.600 |
Why?
| Advisory Committees | 19 | 2025 | 214 | 3.350 |
Why?
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 12 | 2022 | 92 | 3.290 |
Why?
| Immunization Schedule | 22 | 2025 | 196 | 3.260 |
Why?
| Meningococcal Vaccines | 12 | 2025 | 54 | 2.980 |
Why?
| Pregnancy Complications, Infectious | 8 | 2023 | 364 | 2.890 |
Why?
| Clergy | 4 | 2020 | 11 | 2.620 |
Why?
| Physicians, Primary Care | 12 | 2024 | 226 | 2.530 |
Why?
| Health Personnel | 14 | 2024 | 649 | 2.440 |
Why?
| Communication | 15 | 2025 | 841 | 2.320 |
Why?
| Colorado | 39 | 2025 | 4399 | 2.280 |
Why?
| Child | 76 | 2025 | 20805 | 2.190 |
Why?
| Hepatitis B | 4 | 2023 | 63 | 2.190 |
Why?
| Humans | 209 | 2025 | 128499 | 2.140 |
Why?
| Vaccination Coverage | 9 | 2025 | 79 | 2.030 |
Why?
| Pediatrics | 16 | 2021 | 1050 | 2.010 |
Why?
| Respiratory Syncytial Virus Vaccines | 7 | 2025 | 34 | 1.970 |
Why?
| Health Communication | 4 | 2021 | 40 | 1.930 |
Why?
| Viral Vaccines | 4 | 2024 | 94 | 1.930 |
Why?
| Religion | 3 | 2020 | 68 | 1.920 |
Why?
| Pediatricians | 9 | 2024 | 129 | 1.890 |
Why?
| Infant | 49 | 2025 | 9001 | 1.890 |
Why?
| Whooping Cough | 6 | 2022 | 48 | 1.800 |
Why?
| Narration | 2 | 2025 | 57 | 1.770 |
Why?
| United States | 57 | 2025 | 13840 | 1.760 |
Why?
| Pregnancy | 38 | 2025 | 6373 | 1.760 |
Why?
| Attitude to Health | 9 | 2020 | 431 | 1.740 |
Why?
| Female | 127 | 2025 | 68268 | 1.690 |
Why?
| Adult | 75 | 2025 | 35302 | 1.430 |
Why?
| Adolescent | 60 | 2025 | 20304 | 1.400 |
Why?
| Social Media | 4 | 2021 | 137 | 1.380 |
Why?
| Treatment Refusal | 5 | 2020 | 88 | 1.330 |
Why?
| Primary Health Care | 14 | 2024 | 1641 | 1.320 |
Why?
| Health Promotion | 5 | 2020 | 716 | 1.220 |
Why?
| Surveys and Questionnaires | 33 | 2024 | 5371 | 1.200 |
Why?
| Anterior Cruciate Ligament Reconstruction | 6 | 2024 | 124 | 1.180 |
Why?
| Physicians, Family | 10 | 2021 | 203 | 1.170 |
Why?
| Adolescent Health Services | 4 | 2015 | 76 | 1.160 |
Why?
| Child, Preschool | 31 | 2024 | 10487 | 1.100 |
Why?
| Male | 87 | 2025 | 63045 | 1.080 |
Why?
| Safety-net Providers | 3 | 2025 | 109 | 1.070 |
Why?
| Measles | 4 | 2022 | 44 | 1.040 |
Why?
| Prenatal Care | 2 | 2020 | 275 | 1.030 |
Why?
| Physicians | 11 | 2022 | 863 | 1.000 |
Why?
| Rural Health Services | 2 | 2024 | 110 | 0.990 |
Why?
| Infectious Disease Transmission, Vertical | 4 | 2023 | 170 | 0.990 |
Why?
| Diphtheria | 4 | 2022 | 20 | 0.980 |
Why?
| Measles-Mumps-Rubella Vaccine | 3 | 2022 | 41 | 0.980 |
Why?
| Tetanus | 4 | 2022 | 25 | 0.970 |
Why?
| Patient Outcome Assessment | 2 | 2019 | 125 | 0.970 |
Why?
| Pandemics | 6 | 2024 | 1477 | 0.920 |
Why?
| Policy | 3 | 2020 | 144 | 0.920 |
Why?
| Health Care Surveys | 12 | 2021 | 558 | 0.920 |
Why?
| Anterior Cruciate Ligament Injuries | 5 | 2024 | 140 | 0.900 |
Why?
| Practice Guidelines as Topic | 11 | 2023 | 1490 | 0.870 |
Why?
| Osteomyelitis | 2 | 2024 | 123 | 0.860 |
Why?
| Trust | 4 | 2024 | 116 | 0.850 |
Why?
| Ambulatory Care | 4 | 2020 | 504 | 0.850 |
Why?
| Health Equity | 1 | 2024 | 82 | 0.820 |
Why?
| Middle Aged | 45 | 2025 | 30923 | 0.820 |
Why?
| Qualitative Research | 10 | 2024 | 1227 | 0.810 |
Why?
| Physician-Patient Relations | 5 | 2020 | 530 | 0.810 |
Why?
| Religion and Medicine | 2 | 2019 | 25 | 0.800 |
Why?
| Respiratory Syncytial Virus Infections | 5 | 2025 | 119 | 0.800 |
Why?
| Reminder Systems | 4 | 2019 | 174 | 0.790 |
Why?
| Rural Population | 6 | 2024 | 517 | 0.760 |
Why?
| Hepatitis B Vaccines | 4 | 2023 | 47 | 0.750 |
Why?
| Health Services Research | 4 | 2019 | 389 | 0.750 |
Why?
| Urban Population | 4 | 2024 | 441 | 0.740 |
Why?
| Refusal to Treat | 2 | 2020 | 17 | 0.740 |
Why?
| Arthritis, Infectious | 1 | 2022 | 57 | 0.730 |
Why?
| Herpes Zoster Vaccine | 6 | 2022 | 162 | 0.720 |
Why?
| Infant, Newborn | 15 | 2025 | 5740 | 0.720 |
Why?
| Private Practice | 1 | 2020 | 21 | 0.710 |
Why?
| Professional-Patient Relations | 3 | 2018 | 139 | 0.700 |
Why?
| Standing Orders | 2 | 2020 | 11 | 0.700 |
Why?
| Caregivers | 2 | 2025 | 813 | 0.700 |
Why?
| Pneumococcal Vaccines | 6 | 2021 | 140 | 0.700 |
Why?
| Preventive Health Services | 2 | 2020 | 145 | 0.690 |
Why?
| Young Adult | 25 | 2025 | 12349 | 0.680 |
Why?
| Health Care Costs | 3 | 2020 | 366 | 0.670 |
Why?
| Myocarditis | 1 | 2021 | 98 | 0.670 |
Why?
| Anti-Vaccination Movement | 1 | 2019 | 4 | 0.670 |
Why?
| Cross-Sectional Studies | 12 | 2024 | 5045 | 0.670 |
Why?
| Text Messaging | 3 | 2019 | 149 | 0.660 |
Why?
| Stakeholder Participation | 1 | 2020 | 77 | 0.660 |
Why?
| Pregnant Women | 6 | 2022 | 115 | 0.660 |
Why?
| Community Participation | 1 | 2020 | 123 | 0.650 |
Why?
| Freedom | 1 | 2019 | 15 | 0.650 |
Why?
| Healthcare Disparities | 3 | 2024 | 579 | 0.640 |
Why?
| Public Health | 4 | 2024 | 482 | 0.640 |
Why?
| Schools | 2 | 2019 | 436 | 0.630 |
Why?
| Chickenpox Vaccine | 3 | 2017 | 71 | 0.620 |
Why?
| Disease Outbreaks | 3 | 2022 | 347 | 0.620 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 146 | 0.600 |
Why?
| Down Syndrome | 2 | 2021 | 471 | 0.590 |
Why?
| Information Seeking Behavior | 1 | 2018 | 33 | 0.590 |
Why?
| Rotavirus Infections | 2 | 2021 | 45 | 0.580 |
Why?
| Rotavirus Vaccines | 2 | 2021 | 49 | 0.580 |
Why?
| Patient Preference | 2 | 2017 | 185 | 0.570 |
Why?
| Mothers | 5 | 2022 | 729 | 0.570 |
Why?
| Documentation | 2 | 2019 | 183 | 0.570 |
Why?
| Hepatitis A Vaccines | 4 | 2019 | 15 | 0.560 |
Why?
| Cues | 1 | 2019 | 325 | 0.540 |
Why?
| Mass Media | 1 | 2016 | 40 | 0.530 |
Why?
| Physician's Role | 2 | 2019 | 203 | 0.520 |
Why?
| Health Education | 2 | 2018 | 332 | 0.520 |
Why?
| Mumps | 3 | 2022 | 24 | 0.510 |
Why?
| Delivery of Health Care | 3 | 2023 | 889 | 0.490 |
Why?
| School Health Services | 3 | 2015 | 232 | 0.490 |
Why?
| Vaccines, Combined | 4 | 2023 | 48 | 0.480 |
Why?
| Computers, Handheld | 1 | 2015 | 23 | 0.480 |
Why?
| Uterine Cervical Neoplasms | 1 | 2018 | 232 | 0.480 |
Why?
| Dengue Vaccines | 3 | 2019 | 9 | 0.460 |
Why?
| Anthrax Vaccines | 3 | 2018 | 7 | 0.450 |
Why?
| Streptococcal Vaccines | 1 | 2014 | 6 | 0.450 |
Why?
| Cost-Benefit Analysis | 3 | 2024 | 569 | 0.440 |
Why?
| Hepatitis B Surface Antigens | 2 | 2023 | 18 | 0.430 |
Why?
| Recovery of Function | 2 | 2020 | 633 | 0.430 |
Why?
| Internet | 5 | 2019 | 613 | 0.420 |
Why?
| Patient-Centered Care | 2 | 2015 | 497 | 0.400 |
Why?
| Seizures, Febrile | 1 | 2012 | 22 | 0.400 |
Why?
| Washington | 2 | 2025 | 148 | 0.400 |
Why?
| Anti-Bacterial Agents | 5 | 2024 | 1705 | 0.400 |
Why?
| Meningococcal Infections | 3 | 2018 | 23 | 0.390 |
Why?
| Safety | 2 | 2020 | 328 | 0.390 |
Why?
| Nurseries, Hospital | 1 | 2012 | 5 | 0.390 |
Why?
| Herpes Zoster | 3 | 2022 | 317 | 0.390 |
Why?
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2012 | 14 | 0.380 |
Why?
| Streptococcal Infections | 1 | 2014 | 147 | 0.380 |
Why?
| Georgia | 6 | 2021 | 79 | 0.380 |
Why?
| Age Factors | 6 | 2021 | 3122 | 0.370 |
Why?
| Family Practice | 7 | 2017 | 434 | 0.360 |
Why?
| Rotator Cuff | 3 | 2009 | 44 | 0.360 |
Why?
| Skin Diseases, Bacterial | 3 | 2016 | 21 | 0.350 |
Why?
| Mumps Vaccine | 3 | 2021 | 13 | 0.350 |
Why?
| Pertussis Vaccine | 3 | 2022 | 21 | 0.340 |
Why?
| Evidence-Based Medicine | 4 | 2020 | 712 | 0.340 |
Why?
| Retrospective Studies | 15 | 2024 | 14472 | 0.330 |
Why?
| Aged | 19 | 2024 | 21976 | 0.330 |
Why?
| Attitude | 3 | 2021 | 251 | 0.330 |
Why?
| Tenodesis | 1 | 2009 | 19 | 0.320 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2020 | 1358 | 0.310 |
Why?
| Japanese Encephalitis Vaccines | 2 | 2018 | 2 | 0.310 |
Why?
| Vaccines, Contraceptive | 1 | 2008 | 1 | 0.310 |
Why?
| Tendon Injuries | 1 | 2009 | 66 | 0.300 |
Why?
| Egg Proteins | 1 | 2008 | 17 | 0.300 |
Why?
| Health Policy | 1 | 2012 | 351 | 0.300 |
Why?
| Ovulation | 1 | 2008 | 40 | 0.300 |
Why?
| Hepatitis B virus | 2 | 2023 | 35 | 0.300 |
Why?
| Guideline Adherence | 2 | 2013 | 524 | 0.300 |
Why?
| Ovarian Follicle | 1 | 2008 | 63 | 0.290 |
Why?
| Cytomegalovirus | 1 | 2008 | 152 | 0.280 |
Why?
| Societies, Medical | 4 | 2019 | 744 | 0.280 |
Why?
| Mobile Applications | 2 | 2020 | 159 | 0.270 |
Why?
| Professional-Family Relations | 3 | 2018 | 144 | 0.270 |
Why?
| Child Health | 2 | 2019 | 146 | 0.270 |
Why?
| Maternal Health Services | 2 | 2019 | 95 | 0.270 |
Why?
| Vaccines, Synthetic | 3 | 2022 | 126 | 0.270 |
Why?
| Respiratory Syncytial Viruses | 2 | 2023 | 52 | 0.270 |
Why?
| Logistic Models | 3 | 2021 | 1980 | 0.260 |
Why?
| Receptors, Cell Surface | 1 | 2008 | 375 | 0.260 |
Why?
| Data Collection | 3 | 2014 | 649 | 0.250 |
Why?
| Membrane Glycoproteins | 1 | 2008 | 468 | 0.250 |
Why?
| Arthroplasty | 2 | 2003 | 47 | 0.250 |
Why?
| Shoulder Joint | 2 | 2008 | 163 | 0.240 |
Why?
| Time Factors | 4 | 2020 | 6506 | 0.230 |
Why?
| Haemophilus Vaccines | 1 | 2024 | 28 | 0.230 |
Why?
| Databases, Factual | 3 | 2025 | 1267 | 0.230 |
Why?
| Community Health Centers | 1 | 2024 | 57 | 0.230 |
Why?
| Acne Vulgaris | 1 | 2024 | 27 | 0.220 |
Why?
| Pseudotumor Cerebri | 1 | 2024 | 25 | 0.220 |
Why?
| Patient Education as Topic | 2 | 2019 | 734 | 0.220 |
Why?
| Seasons | 2 | 2020 | 498 | 0.220 |
Why?
| Patellar Ligament | 1 | 2024 | 25 | 0.220 |
Why?
| Home Health Aides | 1 | 2023 | 5 | 0.220 |
Why?
| Absenteeism | 1 | 2024 | 47 | 0.220 |
Why?
| Bacterial Vaccines | 1 | 2024 | 62 | 0.220 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2024 | 84 | 0.210 |
Why?
| Blood Coagulation Tests | 1 | 2023 | 60 | 0.210 |
Why?
| Decision Making | 3 | 2020 | 847 | 0.210 |
Why?
| Hospitalization | 8 | 2024 | 2069 | 0.210 |
Why?
| Gout | 1 | 2003 | 33 | 0.200 |
Why?
| Silicone Elastomers | 1 | 2002 | 8 | 0.200 |
Why?
| Hospitals | 3 | 2023 | 637 | 0.200 |
Why?
| Biological Transport | 1 | 2024 | 396 | 0.200 |
Why?
| Antibodies, Monoclonal, Humanized | 2 | 2025 | 758 | 0.200 |
Why?
| Joint Prosthesis | 1 | 2002 | 18 | 0.200 |
Why?
| Thumb | 1 | 2002 | 26 | 0.200 |
Why?
| United Kingdom | 5 | 2024 | 258 | 0.200 |
Why?
| Aged, 80 and over | 6 | 2020 | 7057 | 0.190 |
Why?
| Rubella | 1 | 2022 | 23 | 0.190 |
Why?
| Neisseria meningitidis, Serogroup B | 2 | 2018 | 15 | 0.190 |
Why?
| Infant Health | 1 | 2022 | 24 | 0.190 |
Why?
| Intention | 2 | 2020 | 162 | 0.190 |
Why?
| Russia | 1 | 2021 | 11 | 0.180 |
Why?
| Knee Injuries | 1 | 2022 | 99 | 0.180 |
Why?
| Germany | 1 | 2021 | 98 | 0.180 |
Why?
| Yellow Fever Vaccine | 2 | 2017 | 5 | 0.180 |
Why?
| Risk | 2 | 2015 | 853 | 0.180 |
Why?
| Regression Analysis | 2 | 2020 | 982 | 0.180 |
Why?
| Complementary Therapies | 1 | 2022 | 86 | 0.180 |
Why?
| Hospital Rapid Response Team | 1 | 2021 | 17 | 0.180 |
Why?
| Demography | 2 | 2024 | 278 | 0.180 |
Why?
| General Practitioners | 1 | 2021 | 27 | 0.180 |
Why?
| Clinical Competence | 2 | 2018 | 1009 | 0.180 |
Why?
| Cluster Analysis | 2 | 2022 | 479 | 0.180 |
Why?
| Internal Medicine | 2 | 2014 | 246 | 0.170 |
Why?
| Antiviral Agents | 2 | 2023 | 711 | 0.170 |
Why?
| Osteoarthritis | 1 | 2002 | 166 | 0.170 |
Why?
| California | 2 | 2024 | 398 | 0.170 |
Why?
| Thrombosis | 1 | 2024 | 343 | 0.170 |
Why?
| Hyperglycemia | 1 | 2024 | 326 | 0.170 |
Why?
| Anterior Cruciate Ligament | 2 | 2024 | 80 | 0.170 |
Why?
| Interviews as Topic | 4 | 2024 | 715 | 0.170 |
Why?
| Measles Vaccine | 1 | 2019 | 19 | 0.170 |
Why?
| Drug Storage | 1 | 2020 | 57 | 0.170 |
Why?
| Norovirus | 1 | 2020 | 23 | 0.170 |
Why?
| Fever | 1 | 2021 | 297 | 0.160 |
Why?
| Eligibility Determination | 1 | 2020 | 63 | 0.160 |
Why?
| Personnel Staffing and Scheduling | 1 | 2020 | 88 | 0.160 |
Why?
| Pennsylvania | 1 | 2019 | 107 | 0.160 |
Why?
| State Government | 1 | 2019 | 43 | 0.160 |
Why?
| Government Regulation | 1 | 2019 | 49 | 0.160 |
Why?
| Reimbursement Mechanisms | 1 | 2020 | 84 | 0.160 |
Why?
| Medicaid | 2 | 2021 | 433 | 0.160 |
Why?
| Motivation | 1 | 2024 | 545 | 0.160 |
Why?
| Insurance, Health, Reimbursement | 2 | 2017 | 94 | 0.160 |
Why?
| Gastroenteritis | 1 | 2020 | 67 | 0.160 |
Why?
| Europe | 1 | 2020 | 360 | 0.160 |
Why?
| Risk Factors | 7 | 2024 | 9737 | 0.150 |
Why?
| Morbidity | 1 | 2020 | 301 | 0.150 |
Why?
| Therapeutic Uses | 1 | 2018 | 1 | 0.150 |
Why?
| Pulmonary Alveoli | 1 | 2021 | 365 | 0.150 |
Why?
| Urban Health Services | 1 | 2018 | 60 | 0.150 |
Why?
| Community-Based Participatory Research | 1 | 2019 | 147 | 0.150 |
Why?
| Education, Continuing | 1 | 2018 | 39 | 0.150 |
Why?
| Nuclear Family | 1 | 2018 | 51 | 0.140 |
Why?
| Ambulatory Care Facilities | 2 | 2019 | 228 | 0.140 |
Why?
| Evidence-Based Practice | 2 | 2020 | 208 | 0.140 |
Why?
| Quality Improvement | 3 | 2020 | 1097 | 0.140 |
Why?
| Guatemala | 4 | 2020 | 311 | 0.140 |
Why?
| Altitude | 1 | 2021 | 452 | 0.140 |
Why?
| Cervical Plexus | 1 | 1997 | 1 | 0.140 |
Why?
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 73 | 0.140 |
Why?
| Spinal Nerve Roots | 1 | 1997 | 28 | 0.140 |
Why?
| Hemorrhage | 1 | 2021 | 666 | 0.130 |
Why?
| Travel | 1 | 2017 | 122 | 0.130 |
Why?
| Registries | 3 | 2024 | 1883 | 0.130 |
Why?
| Multivariate Analysis | 1 | 2020 | 1499 | 0.130 |
Why?
| Administrative Personnel | 1 | 2016 | 28 | 0.130 |
Why?
| Pneumococcal Infections | 1 | 2018 | 110 | 0.130 |
Why?
| Cost of Illness | 2 | 2018 | 278 | 0.130 |
Why?
| Behavior Therapy | 1 | 2019 | 236 | 0.130 |
Why?
| Allied Health Personnel | 1 | 2016 | 42 | 0.130 |
Why?
| Adaptation, Psychological | 2 | 2020 | 617 | 0.130 |
Why?
| Physician Executives | 1 | 2016 | 33 | 0.130 |
Why?
| Curriculum | 1 | 2023 | 910 | 0.130 |
Why?
| Vaccines, Conjugate | 2 | 2018 | 63 | 0.130 |
Why?
| Health Services Accessibility | 2 | 2024 | 901 | 0.130 |
Why?
| Diphtheria Toxoid | 1 | 2015 | 12 | 0.130 |
Why?
| Public Health Practice | 1 | 2016 | 64 | 0.130 |
Why?
| Mass Screening | 1 | 2023 | 1146 | 0.130 |
Why?
| Incidence | 2 | 2020 | 2638 | 0.130 |
Why?
| Tetanus Toxoid | 1 | 2015 | 37 | 0.130 |
Why?
| Herpesvirus 3, Human | 1 | 2019 | 331 | 0.120 |
Why?
| Focus Groups | 5 | 2018 | 452 | 0.120 |
Why?
| Minority Groups | 1 | 2018 | 250 | 0.120 |
Why?
| Patient Participation | 1 | 2019 | 409 | 0.120 |
Why?
| Intention to Treat Analysis | 1 | 2015 | 68 | 0.120 |
Why?
| Equipment and Supplies | 1 | 2015 | 41 | 0.120 |
Why?
| Leadership | 1 | 2019 | 352 | 0.120 |
Why?
| Information Dissemination | 1 | 2017 | 204 | 0.120 |
Why?
| Postpartum Period | 1 | 2018 | 331 | 0.120 |
Why?
| Cooperative Behavior | 3 | 2014 | 424 | 0.120 |
Why?
| Brain Neoplasms | 1 | 2024 | 1172 | 0.120 |
Why?
| Zika Virus Infection | 1 | 2017 | 155 | 0.120 |
Why?
| Pre-Exposure Prophylaxis | 1 | 2017 | 203 | 0.120 |
Why?
| Lung Diseases | 1 | 2021 | 715 | 0.120 |
Why?
| Neck Pain | 1 | 2014 | 26 | 0.120 |
Why?
| Occupational Health Services | 1 | 2014 | 31 | 0.120 |
Why?
| Prevalence | 1 | 2021 | 2553 | 0.110 |
Why?
| Prospective Studies | 3 | 2021 | 7069 | 0.110 |
Why?
| Poverty | 1 | 2018 | 497 | 0.110 |
Why?
| Nurses | 1 | 2016 | 164 | 0.110 |
Why?
| State Medicine | 2 | 2024 | 19 | 0.110 |
Why?
| Public Health Administration | 1 | 2014 | 75 | 0.110 |
Why?
| Sexual Behavior | 1 | 2018 | 482 | 0.110 |
Why?
| Emergency Service, Hospital | 1 | 2024 | 1900 | 0.110 |
Why?
| Circovirus | 1 | 2013 | 7 | 0.100 |
Why?
| Clinical Decision-Making | 3 | 2021 | 302 | 0.100 |
Why?
| Adolescent Behavior | 1 | 2018 | 505 | 0.100 |
Why?
| Social Behavior | 1 | 2015 | 288 | 0.100 |
Why?
| Intussusception | 1 | 2013 | 27 | 0.100 |
Why?
| Drug Contamination | 1 | 2013 | 51 | 0.100 |
Why?
| Product Surveillance, Postmarketing | 1 | 2013 | 61 | 0.100 |
Why?
| Workplace | 1 | 2014 | 246 | 0.100 |
Why?
| Parent-Child Relations | 1 | 2015 | 256 | 0.100 |
Why?
| Follow-Up Studies | 3 | 2020 | 4874 | 0.100 |
Why?
| Neisseria meningitidis | 1 | 2011 | 22 | 0.100 |
Why?
| Patient Compliance | 1 | 2016 | 560 | 0.090 |
Why?
| Professional Practice Location | 1 | 2011 | 29 | 0.090 |
Why?
| Electronic Health Records | 1 | 2019 | 974 | 0.090 |
Why?
| Treatment Outcome | 6 | 2024 | 10162 | 0.090 |
Why?
| Outpatients | 1 | 2015 | 368 | 0.090 |
Why?
| Community-Institutional Relations | 1 | 2012 | 94 | 0.090 |
Why?
| Perinatal Care | 1 | 2012 | 54 | 0.090 |
Why?
| Quality of Life | 3 | 2024 | 2688 | 0.090 |
Why?
| Cohort Studies | 3 | 2024 | 5402 | 0.090 |
Why?
| Pneumonia, Pneumococcal | 1 | 2010 | 42 | 0.090 |
Why?
| Swine | 1 | 2013 | 742 | 0.090 |
Why?
| Cognition | 1 | 2018 | 1110 | 0.080 |
Why?
| Pain Measurement | 1 | 2012 | 488 | 0.080 |
Why?
| Hospices | 1 | 2011 | 89 | 0.080 |
Why?
| Sports | 1 | 2012 | 222 | 0.080 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2024 | 2433 | 0.080 |
Why?
| Neuromuscular Diseases | 1 | 2011 | 105 | 0.080 |
Why?
| Activities of Daily Living | 1 | 2012 | 383 | 0.080 |
Why?
| Rotator Cuff Injuries | 1 | 2009 | 57 | 0.080 |
Why?
| Communicable Diseases | 2 | 2022 | 145 | 0.080 |
Why?
| Zona Pellucida Glycoproteins | 1 | 2008 | 2 | 0.080 |
Why?
| Growth Differentiation Factor 9 | 1 | 2008 | 4 | 0.080 |
Why?
| Connexin 43 | 1 | 2008 | 29 | 0.070 |
Why?
| Embryonic Development | 1 | 2008 | 114 | 0.070 |
Why?
| Infertility, Female | 1 | 2008 | 103 | 0.070 |
Why?
| Appointments and Schedules | 2 | 2019 | 81 | 0.070 |
Why?
| Cell Phone | 2 | 2019 | 70 | 0.070 |
Why?
| Tendons | 1 | 2008 | 106 | 0.070 |
Why?
| Leukocytes | 1 | 2008 | 303 | 0.070 |
Why?
| Acute Disease | 3 | 2024 | 965 | 0.070 |
Why?
| Ovary | 1 | 2008 | 210 | 0.070 |
Why?
| Health Surveys | 2 | 2018 | 493 | 0.060 |
Why?
| Mice, Inbred BALB C | 1 | 2008 | 1227 | 0.060 |
Why?
| Fetal Development | 1 | 2008 | 284 | 0.060 |
Why?
| Immobilization | 1 | 2004 | 45 | 0.060 |
Why?
| Homeodomain Proteins | 1 | 2008 | 489 | 0.060 |
Why?
| Algorithms | 2 | 2023 | 1614 | 0.060 |
Why?
| Tetracyclines | 1 | 2024 | 8 | 0.060 |
Why?
| Technology Assessment, Biomedical | 1 | 2024 | 29 | 0.060 |
Why?
| Smallpox Vaccine | 1 | 2024 | 23 | 0.060 |
Why?
| Shoulder Dislocation | 1 | 2004 | 49 | 0.060 |
Why?
| Quality-Adjusted Life Years | 1 | 2024 | 106 | 0.050 |
Why?
| Ligaments | 1 | 2024 | 53 | 0.050 |
Why?
| Palivizumab | 1 | 2023 | 13 | 0.050 |
Why?
| Congresses as Topic | 1 | 2025 | 211 | 0.050 |
Why?
| Acromion | 1 | 2003 | 7 | 0.050 |
Why?
| Neoplasms | 1 | 2018 | 2463 | 0.050 |
Why?
| Health Services | 1 | 2023 | 97 | 0.050 |
Why?
| Joint Instability | 1 | 2024 | 166 | 0.050 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2001 | 29 | 0.050 |
Why?
| Sensitivity and Specificity | 2 | 2023 | 1817 | 0.050 |
Why?
| Hand Strength | 1 | 2002 | 111 | 0.050 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 820 | 0.050 |
Why?
| Psychiatric Nursing | 1 | 2001 | 9 | 0.050 |
Why?
| Dissociative Disorders | 1 | 2001 | 20 | 0.050 |
Why?
| Postoperative Complications | 1 | 2012 | 2462 | 0.040 |
Why?
| Multigene Family | 1 | 2001 | 198 | 0.040 |
Why?
| Cadaver | 2 | 2004 | 306 | 0.040 |
Why?
| Vaccines, Inactivated | 1 | 2021 | 68 | 0.040 |
Why?
| Pain, Postoperative | 1 | 2002 | 222 | 0.040 |
Why?
| Vaccines, Attenuated | 1 | 2021 | 125 | 0.040 |
Why?
| Nurse-Patient Relations | 1 | 2001 | 62 | 0.040 |
Why?
| Transcription Factors | 1 | 2008 | 1635 | 0.040 |
Why?
| Hip Prosthesis | 1 | 2000 | 37 | 0.040 |
Why?
| Inpatients | 1 | 2024 | 468 | 0.040 |
Why?
| Pragmatic Clinical Trials as Topic | 1 | 2020 | 62 | 0.040 |
Why?
| Social Networking | 1 | 2020 | 33 | 0.040 |
Why?
| Maternal Age | 1 | 2019 | 123 | 0.040 |
Why?
| Ultrasonography | 1 | 2003 | 712 | 0.040 |
Why?
| Multicenter Studies as Topic | 1 | 2020 | 286 | 0.040 |
Why?
| Knee Joint | 1 | 2022 | 371 | 0.040 |
Why?
| Nursing Staff, Hospital | 1 | 2001 | 149 | 0.040 |
Why?
| Animals | 2 | 2013 | 34647 | 0.040 |
Why?
| Serogroup | 1 | 2018 | 33 | 0.040 |
Why?
| Pharmacists | 1 | 2021 | 247 | 0.040 |
Why?
| Family | 1 | 2022 | 649 | 0.040 |
Why?
| Crohn Disease | 1 | 2001 | 216 | 0.040 |
Why?
| Respiratory Syncytial Virus, Human | 1 | 2018 | 68 | 0.040 |
Why?
| Awareness | 1 | 2018 | 99 | 0.040 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2017 | 25 | 0.030 |
Why?
| Accessory Nerve | 1 | 1997 | 4 | 0.030 |
Why?
| Risk Assessment | 3 | 2015 | 3232 | 0.030 |
Why?
| Patients | 1 | 2018 | 167 | 0.030 |
Why?
| Educational Status | 1 | 2019 | 470 | 0.030 |
Why?
| Health Plan Implementation | 1 | 2018 | 137 | 0.030 |
Why?
| Costs and Cost Analysis | 1 | 2017 | 200 | 0.030 |
Why?
| Nurse Practitioners | 1 | 2018 | 127 | 0.030 |
Why?
| Genetic Variation | 1 | 2001 | 935 | 0.030 |
Why?
| Insurance Coverage | 1 | 2018 | 219 | 0.030 |
Why?
| Self Report | 1 | 2020 | 797 | 0.030 |
Why?
| Analysis of Variance | 1 | 2018 | 1273 | 0.030 |
Why?
| Models, Theoretical | 1 | 2019 | 542 | 0.030 |
Why?
| Patient Satisfaction | 1 | 2019 | 626 | 0.030 |
Why?
| Pilot Projects | 1 | 2020 | 1568 | 0.030 |
Why?
| Treatment Failure | 1 | 2016 | 338 | 0.030 |
Why?
| Ergonomics | 1 | 2014 | 23 | 0.030 |
Why?
| Decision Support Techniques | 1 | 2018 | 396 | 0.030 |
Why?
| Wound Infection | 1 | 2014 | 29 | 0.030 |
Why?
| Prescriptions | 1 | 2014 | 65 | 0.030 |
Why?
| Efficiency | 1 | 2014 | 91 | 0.030 |
Why?
| Occupational Injuries | 1 | 2014 | 45 | 0.030 |
Why?
| Abscess | 1 | 2014 | 73 | 0.030 |
Why?
| Blood Glucose | 1 | 2024 | 2092 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2021 | 2710 | 0.030 |
Why?
| Sex Factors | 1 | 2019 | 1951 | 0.030 |
Why?
| Program Evaluation | 1 | 2018 | 872 | 0.030 |
Why?
| Cytokines | 1 | 2001 | 1994 | 0.030 |
Why?
| Medically Uninsured | 1 | 2014 | 127 | 0.030 |
Why?
| Genetic Predisposition to Disease | 1 | 2001 | 2269 | 0.030 |
Why?
| Interdisciplinary Communication | 1 | 2014 | 185 | 0.030 |
Why?
| Mice | 1 | 2008 | 16620 | 0.020 |
Why?
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 11 | 0.020 |
Why?
| Pharmaceutical Services | 1 | 2011 | 81 | 0.020 |
Why?
| Biomechanical Phenomena | 2 | 2004 | 766 | 0.020 |
Why?
| Referral and Consultation | 1 | 2014 | 728 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2014 | 2719 | 0.020 |
Why?
| Orthopedic Procedures | 1 | 2008 | 207 | 0.020 |
Why?
| Rotation | 1 | 2004 | 111 | 0.010 |
Why?
| Palliative Care | 1 | 2011 | 717 | 0.010 |
Why?
| Posture | 1 | 2004 | 176 | 0.010 |
Why?
| Exercise | 1 | 2014 | 1918 | 0.010 |
Why?
| Case-Control Studies | 1 | 2010 | 3339 | 0.010 |
Why?
| Range of Motion, Articular | 1 | 2004 | 365 | 0.010 |
Why?
| Machiavellianism | 1 | 2001 | 1 | 0.010 |
Why?
| Nursing Methodology Research | 1 | 2001 | 46 | 0.010 |
Why?
| Helping Behavior | 1 | 2001 | 18 | 0.010 |
Why?
| Linkage Disequilibrium | 1 | 2001 | 257 | 0.010 |
Why?
| Chromium Alloys | 1 | 2000 | 5 | 0.010 |
Why?
| Chromosome Mapping | 1 | 2001 | 504 | 0.010 |
Why?
| Durapatite | 1 | 2000 | 34 | 0.010 |
Why?
| Bone Cements | 1 | 2000 | 41 | 0.010 |
Why?
| Psychological Theory | 1 | 2001 | 99 | 0.010 |
Why?
| Porosity | 1 | 2000 | 94 | 0.010 |
Why?
| Coated Materials, Biocompatible | 1 | 2000 | 56 | 0.010 |
Why?
| Prosthesis Design | 1 | 2000 | 304 | 0.010 |
Why?
| Arthroplasty, Replacement, Hip | 1 | 2000 | 136 | 0.010 |
Why?
| Reoperation | 1 | 2000 | 544 | 0.010 |
Why?
| Survival Analysis | 1 | 2000 | 1265 | 0.010 |
Why?
| Social Support | 1 | 2001 | 589 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2001 | 2064 | 0.010 |
Why?
|
|
O'Leary's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|